Pharmaceutical News

RSS

Online cannabis oils contain dangerous amounts of psychoactive THC

Scientists have published a review in the BMJ which calls for more research and regulations surrounding CBD oils offered by online sellers, after it was found that most contain the psychoactive ingredient THC.

8 Apr 2019

Clinical review offers advice for doctors in prescribing cannabinoids for certain conditions

A clinical review, published today for the BMJ, provides new interim advice for doctors and clinicians in prescribing cannabis-based products and cannabinoids to treat certain conditions.

8 Apr 2019

New research finds anti-inflammatory drugs to be ineffective to prevent Alzheimer’s

Researchers have known for decades that inflammation accompanies Alzheimer's disease brain lesions. Several early studies suggested that "super-aspirins" or Nonsteroidal anti-inflammatory drugs could help avoid the disease.

8 Apr 2019

NSAIDs ineffective for treatment or prevention of Alzheimer's disease

Researchers have known for decades that inflammation accompanies Alzheimer's disease (AD) brain lesions.

5 Apr 2019

UCI discovery may lead to mitigation of side effects caused by erectile dysfunction drugs

In a study published in Science Advances magazine, researchers from the University of California, Irvine have captured, for the first time, the full-length structure of the rod photoreceptor phosphodiesterase 6 (PDE6), an enzyme that plays an indispensable role in human vision.

5 Apr 2019

Patients on immunotherapies should consume more fiber, fewer probiotics

A new study has found that taking probiotics could drastically reduce the response of cancer patients to immunotherapy. Patients on a fiber-rich diet showed a five-fold increase in response.

5 Apr 2019

FDA extends indication of metastatic breast cancer treatment to include male patients

The U.S. Food and Drug Administration today is extending the indication of Ibrance (palbociclib) capsules in combination with specific endocrine therapies for hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative advanced or metastatic breast cancer in male patients.

5 Apr 2019

Polypharmacy in old age increases risk of adverse side effects

As people get older, the more likely they are to take several different medicines on a regular basis. However, this increases the risk of adverse effects, including interactions between the various active agents.

4 Apr 2019

Drug that looks at Alzheimer’s differently ready for its first in-human testing

Alzheimer's disease wreaks emotional havoc on patients, who are robbed of their memories, their dignity, and their lives.

4 Apr 2019

Researchers uncover gender differences in reports of adverse drug reactions

In a British Journal of Clinical Pharmacology study, investigators uncovered numerous gender differences in reports of adverse drug reactions sent to the National Pharmacovigilance Centre in the Netherlands.

3 Apr 2019

Study provides insights on liver injury in men taking body building supplements

In a study reported in Alimentary Pharmacology & Therapeutics, 44 men with liver injury, attributed to over-the-counter bodybuilding supplements, experienced a uniform and distinctive pattern of signs and symptoms that were often prolonged, difficult to treat, and accompanied by disability and weight loss.

3 Apr 2019

Sleeping pill use may indicate future need for greater hypertension treatment

In a Geriatrics & Gerontology International study of 752 older adults with hypertension followed from 2008-2010 through 2012-2013, using sleeping pills on a regular basis was linked with use of an increasing number of blood pressure medications over time.

3 Apr 2019

Common pain reliever may increase stroke risk in people with diabetes

Acetaminophen (otherwise known by brand names such as Tylenol) is one of the most widely used pain relievers.

3 Apr 2019

Study suggests HLD200 could provide novel, more flexible alternative to treating ADHD

A new three-part study showed that a delayed-release, extended-release form of methylphenidate could be given to adults in the evening with or without food and would not exert any clinically meaningful effect for at least 10 hours after administration.

2 Apr 2019

New guidance on use of valproate in women, girls of child bearing age with epilepsy published

New guidance to support regulations around the use of valproate in women and girls of child bearing age with epilepsy has been published by specialists from 13 UK healthcare bodies including seven Royal Colleges.

2 Apr 2019

Study: Most American allergists prescribe under-the-tongue allergy tablets

Allergy shots (subcutaneous immunotherapy or SCIT) have been available for more than 100 years. Allergy tablets (sublingual immunotherapy or SLIT) have been approved by the Food and Drug Administration for use in the United States for four years.

2 Apr 2019

ACR releases new drug pricing and step therapy position statements

The American College of Rheumatology has released new drug pricing and step therapy position statements that they hope legislators will consider as they continue to explore policy and regulatory options to make drugs more affordable and accessible.

2 Apr 2019

FDA issues warning letters to four homeopathic firms for CGMP violations

The U.S. Food and Drug Administration today posted warning letters to four companies who produce homeopathic drug products for significant violations of current good manufacturing practice regulations, including a letter to King Bio Inc. of Asheville, N.C.

2 Apr 2019

Single dose long lasting opioid antidote on the horizon

Recent reports have shown a 1,000 percent rise in opioid abuse (especially synthetic drug Fentanyl) in the United States over the past one decade. In 2017 for example there have been 47,000 deaths attributed to opioid overdose says the US Centre for Disease Control and Prevention (CDC).

31 Mar 2019

FDA approves new oral drug to treat relapsing forms of multiple sclerosis

The U.S. Food and Drug Administration today approved Mavenclad (cladribine) tablets to treat relapsing forms of multiple sclerosis (MS) in adults, to include relapsing-remitting disease and active secondary progressive disease.

29 Mar 2019